DUBLIN (AP) — DUBLIN (AP) — Avadel Pharmaceuticals PLC (AVDL) on Tuesday reported a loss of $2.6 million in its third quarter.

The Dublin-based company said it had a loss of 3 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.

The specialty pharmaceutical company posted revenue of $50 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $49.1 million.

Avadel shares have increased 15% since the beginning of the year. The stock has increased 47% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL